Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

被引：0

作者：

Mei Gao

Miranda Lin

Richard A. Moffitt

Marcela A. Salazar

Jinha Park

Jeffrey Vacirca

Chuan Huang

Kenneth R. Shroyer

Minsig Choi

Georgios V. Georgakis

Aaron R. Sasson

Mark A. Talamini

Joseph Kim

机构：

[1] University of Kentucky,Department of Surgery

[2] University of Kentucky,Markey Cancer Center

[3] State University of New York,Department of Pathology

[4] City of Hope,Department of Experimental Therapeutics

[5] University of Iowa,Department of Radiology

[6] East Setauket,New York Cancer Specialists

[7] State University of New York,Departments of Radiology

[8] State University of New York,Departments of Psychiatry

[9] State University of New York,Departments of Medicine

[10] State University of New York,Departments of Surgery

来源：

British Journal of Cancer | 2019年 / 120卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：88 / 96

页数：8

共 50 条

[21] Small-Molecule Immune Checkpoint Inhibitors Targeting PD-1/PD-L1 and Other Emerging Checkpoint Pathways
Sasikumar, Pottayil G.
Ramachandra, Murali
BIODRUGS, 2018, 32 (05) : 481 - 497
[22] Dual immunotherapy targeting macrophages and PD-1 immune checkpoint for treatment of melanoma.
Shudde, Claire E.
Patel, Jalpa
Rajan, Robin
Shmeeda, Hilary
Dung Nguyen
Gabizon, Alberto A.
La-Beck, Ninh M.
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 96 - 96
[23] Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immune-suppressive environment in pancreatic cancer
Zhang, Yaqing
Mathew, Esha
Velez-Delgado, Ashley
Long, Kristen B.
Li, Dongjun
Mendez, Flor M.
Flannagan, Kevin
Rhim, Andrew D.
Simeone, Diane M.
Beatty, Gregory L.
di Magliano, Marina Pasca
CANCER RESEARCH, 2016, 76
[24] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
Peng, Zikun
Li, Ming
Li, Huayi
Gao, Qinglei
DRUG DISCOVERY TODAY, 2023, 28 (08)
[25] Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer
AmeliMojarad, Mandana
AmeliMojarad, Melika
Cui, Xiaonan
PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
[26] PD-1 IMMUNE CHECKPOINT BLOCKADE ENHANCES ERADICATION OF DISSEMINATED OVARIAN CANCER
Serda, Rita
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A438 - A438
[27] Prognostic Signature of Response to PD-1 Immune Checkpoint Blockade in Lung Cancer
Ding, Juan
Sun, Tingting
Yao, Juan
Zheng, Ni
Lu, Rong
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02): : 617 - 628
[28] The role of immune checkpoint PD-1 in the submandibular gland
Borys, Samantha
Brossay, Laurent
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[29] The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
Derosa, Lisa
Routy, Bertrand
Kroemer, Guido
Zitvogel, Laurence
ONCOIMMUNOLOGY, 2018, 7 (06):
[30] Targeting the Immune Checkpoint Pathway Produces Direct Binding, Uptake, and Cytotoxicity in Pancreatic Cancer
Kim, Joseph
Gao, Mei
Park, Jinha
Turkman, Nashaat
Choi, Minsig
Vacirca, Jeffrey L.
Sasson, Aaron R.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E34 - E35

← 1 2 3 4 5 →